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Inflammatory NF-kB/RelA activation is medi-
ated by the three canonical inhibitors, IkBa, -b,
and -3. We report here the characterization of
a fourth inhibitor, nfkb2/p100, that forms two
distinct inhibitory complexes with RelA, one of
which mediates developmental NF-kB activa-
tion. Our genetic evidence confirms that p100
is required and sufficient as a fourth IkB protein
for noncanonical NF-kB signaling downstream
of NIK and IKK1. We develop a mathematical
model of the four-IkB-containing NF-kB signal-
ing module to account for NF-kB/RelA:p50 acti-
vation in response to inflammatory and devel-
opmental stimuli and find signaling crosstalk
between them that determines gene-expres-
sion programs. Further combined computa-
tional and experimental studies reveal that
mutant cells with altered balances between
canonical and noncanonical IkB proteins may
exhibit inappropriate inflammatory gene ex-
pression in response to developmental signals.
Our results have important implications for
physiological and pathological scenarios in
which inflammatory and developmental signals
converge.
INTRODUCTION
The transcription factor NF-kB plays critical roles in di-
verse physiological processes (Ghosh and Karin, 2002)
and numerous human pathologies (Karin et al., 2004).
The primary mediator of NF-kB transcriptional activity is
a RelA:p50 heterodimer. Mouse knockout studies have
confirmed that RelA is responsible for the expression of
a large number of genes involved in inflammatory re-
sponses as well as in cell proliferation, cell adhesion,and tissue remodeling (Hoffmann and Baltimore, 2006).
NF-kB activity is inducible by a diverse range of stimuli
(www.nf-kb.org); these include pathogen derived sub-
stances and intercellular mediators of inflammation,
immune cell maturation, and secondary lymphoid organ
development. Understanding the mechanisms that regu-
late NF-kB activity is critical for developing therapeutic
strategies for many human diseases (Ghosh and Karin,
2002; Hoffmann and Baltimore, 2006; Karin et al., 2004).
Induction of NF-kB/RelA activity in response to inflam-
matory stimuli does not require protein synthesis. Instead,
early experiments distinguished between two activation
mechanisms: a precursor processing mechanism or
regulation by a separate inhibitor protein. The detergent
deoxycholate was shown to liberate fully active kB-site
DNA binding activity in unstimulated cells, suggesting
the existence of a separate inhibitor protein(s), termed
IkB (Baeuerle and Baltimore, 1988). Three IkB proteins
(IkBa, -b, or -3) have been identified, which share the
bona fide IkB properties of (1) binding NF-kB dimers,
thereby inhibiting their DNA binding activity and retaining
them in a latent state, and (2) allowing for NF-kB activation
by undergoing stimulus-induced proteolysis. The canoni-
cal signaling pathway involves the stimulus-responsive
phosphorylation of the IkBs by the NEMO and IKK2
containing kinase complex, which tags them for degrada-
tion via the ubiquitin-proteasome pathway. Several other
IkB-like ankyrin-repeat containing NF-kB binding proteins
have been reported to modulate nuclear NF-kB transcrip-
tional activity on a subset of genes (Yamamoto et al.,
2004) or, when overexpressed, prevent nuclear localiza-
tion of NF-kB (Hatada et al., 1992; Inoue et al., 1992;
Naumann et al., 1993). However, during inflammatory
signaling the dynamic control of NF-kB nucleocytoplas-
mic localization is mediated by the three classical IkB
proteins. A detailed molecular understanding of the
biochemical events has allowed for the construction of
a mathematical model that recapitulates the experimen-
tally observed signaling behavior in response to inflamma-
tory stimuli (Hoffmann et al., 2002; Kearns et al., 2006;
Werner et al., 2005).Cell 128, 369–381, January 26, 2007 ª2007 Elsevier Inc. 369
In contrast, a second NF-kB activation pathway is
thought to regulate the activity of NF-kB/RelB dimers via
a precursor processing mechanism. This signaling path-
way is activated in response to developmental signals
such as those transduced by lymphotoxin b receptor
(LTbR) and RANK, which are required for lymph node
and osteoclast genesis and homeostasis (Senftleben
et al., 2001; Weih and Caamano, 2003), or BAFFR,
CD40, and CD27, which regulate B cell survival and prolif-
eration (Ramakrishnan et al., 2004; Zarnegar et al., 2004).
The activation mechanism was shown to involve NF-kB-
inducing kinase (NIK) and IKK1-dependent phosphoryla-
tion of the nfkb2 gene product p100 (Dejardin et al.,
2002), which triggers its proteasomal processing. This
partial proteolysis event removes a C-terminal ankyrin
repeat domain (ARD) to generate the NF-kB protein p52
(Senftleben et al., 2001). Interestingly, only newly synthe-
sized p100 was shown to undergo processing to generate
nuclear p52-containing nuclear NF-kB activities (Mord-
muller et al., 2003).
The physiological role of LTbR is to transduce signals
from hematopoietically derived lymphoid tissue inducer
cells expressing membrane bound lymphotoxin (LTab) to
mesenchymal or stromal cells to initiate critical steps in
lymph node development (Mebius, 2003; Rennert et al.,
1998). LTbR stimulation results in both RelA- and RelB-
containing NF-kB dimers (Muller and Siebenlist, 2003).
The vascular-cell adhesion molecule 1 (VCAM1), a promi-
nent RelA target gene, mediates early steps in lymph node
genesis, the formation of lymph node anlagen during
embryogenesis. Subsequently, homing of B cells, whose
interaction with stromal cells is critical for lymph node
and splenic microarchitecture, requires lymphoid chemo-
kines SLC/CCL21 and BLC/CXCL13, whose expression is
thought to involve RelB (Bonizzi et al., 2004). The matura-
tion of spleen and lymph nodes and continued influx and
organization of lymphocytes in these secondary lymphoid
organs during adulthood is also dependent on LTbR sig-
naling and the expression of the RelA target gene Mad-
CAM (Browning et al., 2005). The phenotypes of knockout
mice reflect the requirement of both RelA- and RelB-
containing NF-kB activities. While RelA deficiency results
in a complete absence of lymph nodes in newborn mice
indicating an early organogenic defect (Alcamo et al.,
2002), RelB appears to be required for their maintenance
as RelB-deficient mice exhibit deterioration of nodes
following birth (Weih et al., 2001).
Despite the importance of RelA activity in lymph node
genesis, the molecular mechanism responsible for
LTbR-induced RelA:p50 dimer activation has remained
unclear. Both an IkB-dependent (Muller and Siebenlist,
2003) and an IkB-independent (Jiang et al., 2003) activa-
tion mechanism have been proposed, and for CD27
signaling the noncanonical signal transducer NIK has
been implicated (Ramakrishnan et al., 2004). Here we
report the existence of a fourth bona fide IkB protein
that mediates RelA:p50 activation in response to nonca-
nonical NF-kB signaling pathways. Reconstruction of the370 Cell 128, 369–381, January 26, 2007 ª2007 Elsevier Inc.signaling mechanism in a mathematical model allowed
us to demonstrate that this mechanism is sufficient to
account for the experimental observables and explore
signaling crosstalk in cells exposed to diverse NF-kB
inducing stimuli.
RESULTS AND DISCUSSION
NF-kB/RelA Activation without IkB Degradation
Current pathway maps of LTbR signaling posit that IKK1-
dependent processing of the nfkb2 gene product p100 to
p52 results in the nuclear localization of a RelB:p52 dimer.
However, the activation mechanism of RelA-containing
dimers remains unclear and is generally thought to involve
the IKK2-IkB-NF-kB signaling module that also allows for
signal transduction of inflammatory stimuli (Figure 1A). As
we previously recapitulated NF-kB/RelA activation in
response to tumor necrosis factor receptor (TNFR) and
Toll-like receptor (TLR)-4 stimulation in a mathematical
model, we set out to examine the mechanism of NF-kB/
RelA activation downstream of LTbR in a genetically
tractable cell culture system to similarly reconstitute the
underlying signaling mechanism in silico.
We stimulated mouse embryonic fibroblasts (MEF) with
an agonistic antibody raised against LTbR that was shown
to functionally complement for the genetic absence of
LTab (Rennert et al., 1998). Using subsaturating concen-
trations of antibody that resulted in specific signaling
events (Figures S1A–S1H), we detected nuclear NF-kB
DNA binding activity (Figure 1B) that consisted of both
RelA:p50 and RelB:p50 dimers (Figure 1C), as previously
described (Derudder et al., 2003).
One of the critical steps in NF-kB/RelA activation in
response to inflammatory stimuli is NEMO-dependent
IKK phosphorylation and degradation of RelA bound
IkBs. Immunoprecipitated IKK activity could be detected
in response to very low concentrations (0.01 ng/ml) of
TNF (Figure 1D, lanes 7–12), but, surprisingly, nonsaturat-
ing LTbR stimulation conditions did not elicit any NEMO-
associated IKK activity (Figure 1D, lanes 18–22). Consis-
tently, cytoplasmic immunoblotting revealed no decrease
in IkB protein levels (Figure 1E, lanes 8–11) and no induc-
ible IkBa phosphorylation (Figures S1I and S1J).
nfkb2 p100 Is an Inhibitor of NF-kB/RelA:p50 DNA
Binding Activity
These observations led us to search for novel factors that
regulate NF-kB/RelA dimers in response to noncanonical
stimuli. To this end we utilized a cell line deficient in the
three canonical IkB proteins, IkBa, -b, and -3 (ikb/). Ini-
tial biochemical characterization revealed that despite the
loss of these known NF-kB inhibitors, only a small fraction
of cellular RelAwas constitutively nuclear, while themajor-
ity of RelA was still cytoplasmic (Figure 2A), consistent
with observations in IkB knockdown cells (Tergaonkar
et al., 2005). To investigate the molecular basis for
cytoplasmic sequestration, we reconstituted a cell line
also lacking the rela gene (ikb/rela/) with a tandem
Figure 1. LTbR-Induced NF-kB/RelA Dimer Activation Does Not Correlate with Canonical IkB Kinase Activity or IkB Degradation
(A) A current model of NF-kB activation mechanisms resulting in RelA:p50 and RelB:p52 dimer activation via the canonical (IKK2) and the noncanon-
ical (IKK1) pathway, respectively. The pathway that mediates NF-kB/RelA dimer activation in response to noncanonical stimuli has not been
elucidated.
(B) Nuclear NF-kB DNA binding activities (arrows and arrowhead) induced by 1 ng/ml of TNF, 10 mg/ml or 0.3 mg/ml of LTbR agonistic antibody were
resolved by EMSA with a kB-site containing probe. Asterisk denotes a nonspecific DNA-protein complex.
(C) The composition of NF-kB DNA binding activities induced upon LTbR receptor ligation was examined by supershift analysis using the indicated
antibodies (lanes 2–8). At 5 hr poststimulation, RelA:p50 (arrow) and RelB:p50 (arrowhead) dimers were detected.
(D) IKK kinase activity was monitored by incubating GST-IkBa with anti-NEMO coimmunoprecipitates from extracts prepared from MEF stimulated
with 1 ng/ml TNF, 0.01 ng/ml TNF, or with 10 mg/ml a-LTbR antibody, 0.3 mg/ml a-LTbR antibody. Reaction mixtures were resolved in SDS-PAGE and
used for autoradiography (top) or immunoblotting (bottom) of coprecipitated IKK1 as a loading control.
(E) IkBa and -b immunoblot of extracts prepared from TNF- (red lines) or LTbR- (green and blue lines) stimulated cells. Signals were quantitated,
normalized to the actin loading control, and graphed relative to signal levels in resting cells (bottom panel).epitope-tagged form of RelA (TAP-RelA) by retrovirus-
mediated transduction (Figure S2A).
Tandem affinity purification of epitope-tagged RelA in
nondenaturing conditions followed by silver staining of
purified proteins separated on SDS-PAGE as well as
mass-spectrometric analysis revealed nfkb1 p50 and
nfkb2 p100 as the two major interacting proteins (Fig-
ure 2B). Coimmunoprecipitation analysis confirmed that
p100 was bound to RelA not only in IkBa/b/3-deficient
(Figures 2C and S2B, right panels) but also wild-type
extracts (Figures 2C and S2B, left panels). Interestingly,
a comparison of immunoprecipitates of RelA and RelB
revealed that p100 was distributed evenly between RelB
and RelA bound complexes in wild-type cells (Figure 2D).
We employed the detergent deoxycholate (DOC) to
disrupt the interaction of endogenous IkB proteins and
NF-kB (Baeuerle and Baltimore, 1988) and reveal theDNA binding activity (Figure 2E, compare lanes 1 and 2)
of a RelA:p50 dimer (Figure S2C, top panel) in cytoplasmic
extracts prepared from unstimulated wild-type MEF. As
expected, prior immunodepletion of IkBa from the extract
removed the majority of latent NF-kB DNA binding activity
(lane 3). However, immunodepletion of p100 also resulted
in a significant loss in DOC-inducible DNA binding activity,
while immunodepletion of p105 did not (lanes 4 and 5).
These results suggest that a fraction of cytoplasmic
RelA:p50 dimer is not bound to canonical IkB proteins
but to p100. Strikingly, treating ikba/b/3/ cyto-
plasmic extracts with DOC liberated latent NF-kB DNA
binding activity composed of RelA and p50 (Figures 2E,
lanes 6 and 7, and S2C, bottom panel). Prior immunode-
pletion of p100 specifically eliminated almost all of the
DOC-induced DNA binding activity (Figure 2E, lanes 8
and 9).Cell 128, 369–381, January 26, 2007 ª2007 Elsevier Inc. 371
Figure 2. nfkb2 p100 Is an Inhibitor of the RelA:p50 DNA Binding Activity
(A) Subcellular localization of RelA in wild-type and ikba/b/3/MEF (ikb/) was revealed by immunoblot of cytoplasmic (CE) and nuclear (NE)
extracts. Signals were quantitated, and respective percentages of total are indicated below the blot. An immunoblot for the TFIID component TAF20
(a.k.a. TAF12) served as a fractionation control.
(B) Silver-stained SDS-PAGE of tandem affinity purified (TAP)- p65 protein expressed by a retroviral transgene in ikba/b/3/rela/MEF. Mock
purification from equivalent extracts prepared from the parental MEF confirms the specificity of the associated proteins. LC-MS/MS analysis revealed
that indicated gel slices contained p100, p65, and p50 proteins respectively.
(C) Immunoblots of RelA coimmunoprecipitates prepared from wild-type (left panel) or IkBa/b/3-deficient (right panel) MEF lysates revealed RelA
association with IkBa, p50, p100, and p105 proteins. Lysate corresponding to half as many cells as the immunoprecipitate was probed as a control.
(D) The fractions of cellular p100 or p105 bound to RelA or RelBwere examined by immunoblots of RelA or RelB immunoprecipitate (IP) and compared
to 50% cell equivalent of crude lysate or flowthrough (FT).
(E) Latent cytoplasmic NF-kB DNA binding activity in wild-type (left panel) or IkBa/b/3-deficient cells (right panel) were revealed by deoxycholate
(DOC) treatment and EMSA (lanes 2 and 7). Prior immunodepletion with the indicated antibodies removed the target protein along with associated
latent NF-kB activity. An immunoblot (bottom panel) against actin served as a loading control.
(F) IkBa/b/3-deficient MEF were subjected to p100 knockdown by lentivirus-mediated delivery of a specific shRNA. Lysates prepared from resulting
ikb/p100KD and parental ikb/ cells were compared by immunoblots for indicated proteins (left panel). Similarly, nuclear extracts were compared
for NF-kB DNA binding activity by EMSA (right panel).
(G) Specificity and composition of the constitutive NF-kB DNA binding complexes present in the indicated nuclear extracts were determined by
oligonucleotide competition (lanes 2 and 3) and supershift analysis with indicated antibodies (lanes 4–6).These biochemical results prompted us to examine the
RelA:p50-p100 interaction genetically. Lentiviral delivery
of small hairpin RNA (shRNA) to ‘‘knockdown’’ nfkb2 ex-
pression in IkBa/b/3-deficient cells resulted in more than
90% reduction of p100/p52 protein levels (Figure 2F, left
panel). Importantly, electrophoretic mobility shift assay
(EMSA) with nuclear extracts prepared from these ikb//
p100KD cells showed an 5-fold increase in the NF-kB
activity over controls (Figures 2F, right panel, and S2E).
Supershift analysis confirmed that the majority of this
DNA binding activity consisted of RelA:p50 dimers372 Cell 128, 369–381, January 26, 2007 ª2007 Elsevier Inc.(Figure 2G, data not shown). In sum, our results demon-
strated that, analogous to the canonical IkB proteins,
p100 is able to sequester RelA:p50 dimers in the
cytoplasm and inhibit their DNA binding activity in a
DOC-sensitive manner.
nfkb2 p100 Is a Stimulus-Responsive Regulator
of NF-kB/RelA:p50 Activity
We sought to examine the stimulus-responsive behavior
of p100 bound to RelA:p50 dimers. By immunopreci-
pitating RelA in nondenaturing conditions from cellular
Figure 3. nfkb2 p100 Is a Stimulus-Responsive Regulator of the NF-kB/RelA Dimer
(A) Association of p100 and RelA during LTbR signaling was monitored by p100 immunoblotting of RelA coimmunoprecipitates performed with
extracts prepared from wild-type cells at the indicated times. Immunoblots for p65 and p50 served as a control for coIP efficiency. ‘‘*’’ indicates
a nonspecific band.
(B) The requirement of specific domains of p100 in LTbR-induced NF-kB/RelA activation was examined. NF-kB/RelA activation was scored by EMSA
(top panel) and by immunoblotting (bottom panels) nuclear extracts prepared from LTbR agonist treated nfkb2/MEF or nfkb2/MEF stably trans-
duced with retrovirus expressing full-length p100, a mutant that lacks the C-terminal stimulus-responsive phosphorylation sites (‘‘p1001-774’’),
a C-terminal truncated protein that lacks the IkB-like domain (‘‘p52’’), or an N-terminal truncated protein that lacks RHD (‘‘IkBd’’).
(C) EMSA of NF-kB DNA binding induced in ikba/b/3/ cells by TNFR (left panel) or LTbR (right panel, lanes 5–8) stimulation for the indicated
times. The effect of p100 knockdown in ikba/b/3/ cells on the inducibility of NF-kB DNA binding activity by LTbR stimulation was monitored
similarly by EMSA (right panel, lanes 9–12).
(D) RelA interactions with p100 via the RHD or ARD were distinguished by deoxycholate (DOC) sensitivity. RelA-immunoprecipitates prepared from
cytoplasmic extracts from resting (left panel) or LTbR agonist treated (right panel) cells were washed with increasing concentrations of DOC. Washes
and immunoprecipitates were examined by immunoblotting with indicated antibodies.
(E) LTbR-induced proteolysis of pre-existing or de novo synthesized p100 protein was monitored using pulse-chase in vivo labeling. N-terminal p100
antibody was used in immunoprecipitates with extracts prepared from prelabeled cells at the indicated time points of an LTbR time course (lanes 1–3,
‘‘chase’’), and from cells labeled during the later phase of mock or LTbR time course (lanes 4 and 5, ‘‘pulse’’). Similarly treated extracts from nfkb2/
cells (lane 6) served to identify nonspecific bands.
(F) Multiple nfkb2 p100 NF-kB complexes are functionally distinct: we propose to distinguish between self-inhibited dimeric complexes of p100
and RelA or RelB, which are unresponsive to LTbR signaling, and stimulus-responsive ternary complexes in which the IkBd domain of p100 inhibits
functional RelA:p50 and RelB:p50 dimers in trans.
(G) Increased p52 association with p100 following LTbR signaling. Immunoblot for p52/p100 proteins of p100 C-terminal domain immunoprecipitates
prepared from indicated cell extracts.extracts, we found that LTbR stimulation led to a decrease
in RelA-associated p100 protein (Figure 3A), suggesting
that p100maymediate NF-kB/RelA activation in response
to LTbR stimulation. Using a genetic approach, we found
that LTbR stimulation of nfkb2/ cells were not only
deficient in RelB activation as reported (Derudder et al.,
2003; Lo et al., 2006) but that NF-kB/RelA activation was
also abrogated (Figure 3B, top panel, lanes 1–4). Recon-stitution of nfkb2/ MEF with retrovirally expressed
p100 restored LTbR-inducible RelA and RelB DNA binding
activities and RelA translocation (Figure 3B, lanes 5–8)
concomitant with p100 degradation (Figure S3A). Interest-
ingly, reconstitution of nfkb2/ cells with the processed
p52 protein did not restore signal inducible RelA nuclear
activity indicating the requirement for the IkB-like ankyrin
repeat domain of p100 (Figure 3B, lanes 13–16). Further,Cell 128, 369–381, January 26, 2007 ª2007 Elsevier Inc. 373
a mutant form of p100 lacking the C-terminal signal re-
sponsive phosphorylation sites also did not functionally
complement the knockout cells (Figure 3B, lanes 9–12).
Strikingly, expression in nfkb2/ MEFs of the C-terminal
portion of p100 containing the ankyrin repeat domain
(IkBd) was sufficient for at least partial RelA:p50 activation
upon LTbR ligation (Figure 3B, lanes 17–20).
To examine whether nfkb2 p100 is sufficient for NF-kB/
RelA activation or the canonical IkB proteins are also
required, ikba/b/3/ cells were examined in stimula-
tion time courses. While the elevated nuclear RelA:p50
activity in these cells was not further inducible by TNF
(Figure 3C, lanes 1–4), LTbR stimulation resulted in strong
induction of both nuclear RelA and RelB proteins and DNA
binding activities with kinetics that were similar to those
observed in wild-type cells (Figures 3C, lanes 5–8, and
S3B–S3D). Activation of NF-kB binding activities in
ikba/b/3/ cells was accompanied by loss in cellular
and RelA-associated p100 protein (Figures S3E and S3F).
Furthermore, we found that LTbR signaling to NF-kB was
abrogated in ikb//p100KD (Figure 3C, lanes 9–12). Col-
lectively, these analyses provide biochemical and genetic
evidence for the requirement and sufficiency of p100 as
a stimulus-specific regulator of RelA dimers in response
to noncanonical signaling triggered by LTbR stimulation.
Multiple nfkb2 p100 NF-kB Complexes
Are Functionally Distinct
Unlike canonical IkBs, nfkb2 p100 is not only capable of
interacting with RelA:p50 dimers in trans via its IkBd do-
main as revealed by DOC-treated extracts analyzed by
EMSA (Figure 2E), it can also dimerize with other NF-kB
proteins via its Rel homology domain (RHD). Thus p100
is capable of forming complexes with NF-kB of distinct
molecular architectures. To characterize the architecture
of the complex(es) relevant for noncanonical signaling,
we mapped DOC-sensitive and -insensitive interactions
between RelA and p100 during LTbR signaling (Figure 3D).
In resting cells (lanes 1–6), we found that most but not all
p100 could be DOC-stripped off immunoprecipitated
RelA proteins (top panel). In contrast, in LTbR-stimulated
cells (lanes 7–12), no DOC-sensitive p100 could be
detected in the RelA immunoprecipitate, while the DOC-
resistant fraction remained. Efficient stripping of IkBa
and retention of p50 in the RelA immunoprecipitate con-
firmed the specificity of the DOC strip conditions. Similar
analyses of canonical IkBa/b/3-deficient cells (Figure S3G)
also revealed that DOC-sensitive p100-RelA complexes
are responsive to LTbR signaling.
Given that the IkBd domain is genetically sufficient for
LTbR induction of RelA:p50 dimer (Figure 3B), we exam-
ined biochemically the fate of the p100 RHDduring nonca-
nonical signaling. To this end, cellular proteins were pulse
labeled with 35S-methionine before adding the receptor
agonist. Immunoprecipitates obtained with an N-terminal
p100 RHD antibody revealed 35S-labeled p100 prior to
stimulation (Figure 3E, lane 1). Interestingly, LTbR stimula-
tion led to the conversion of this pre-existing p100 to374 Cell 128, 369–381, January 26, 2007 ª2007 Elsevier Inc.a polypeptide (lane 2) of the same molecular weight as
the p52 generated de novo during LTbR signaling (lane
5). However, while de novo generated p52 protein partic-
ipates in the LTbR-induced NF-kB DNA binding activities
(Figure S1C), the p52 protein generated from pre-existing
p100 complexes does not (Figures 1C and S3C).
To summarize our data we propose the following
molecular architectures of p100 complexes (Figure 3F).
LTbR-unresponsive complexes of p100 include the previ-
ously identified ‘‘self-inhibited’’ p100:RelA, p100:RelB,
p100:p50, and p100:p52 dimers in which the IkBd domain
of p100 folds back onto the dimer to inhibit its DNA binding
activity in cis (Beinke and Ley, 2004; Mercurio et al., 1993;
Naumann et al., 1993). In addition, two p100 proteins may
form a necessarily asymmetric dimer, analogous to two
p105 proteins (Moorthy and Ghosh, 2003; Moorthy et al.,
2006). In that complex, one of the IkBd domains would
inhibit the DNA binding activity of the p52 homodimer,
while the other IkBd domain would be available to inhibit
a RelA:p50 or a RelB:p50 dimer. Our results suggest that
this second IkBd domain is sensitive to LTbR signaling to
undergo proteolysis leaving the C-terminal RHD intact.
The remaining p100:p52 complex would be self-inhibited
and therefore incapable of participating in NF-kB DNA
binding activity. However, during the later phase of LTbR
signaling de novo synthesized p52 dimerizes with Rel
proteins via the RHD and contributes to nuclear DNA
binding activity as previously observed (Dejardin et al.,
2002; Muller and Siebenlist, 2003).
Based on these proposed functional roles of distinct
p100 complexes, we would predict that the amount of
p52 protein associated with p100 increases during the
early phase of LTbR signaling. Indeed, immunoprecipita-
tion of p100 with an antibody specific for the C-terminal
IkBd domain yields more coprecipitating p52 protein at
the 5 hr time point of LTbR signaling than in resting cells
(Figure 3G).
Noncanonical Signaling to NF-kB/RelA Activation
Activation of RelB dimers in the noncanonical signaling
pathway was shown to depend on signal-responsive
NIK-dependent activation of IKK1 (Beinke and Ley,
2004; Senftleben et al., 2001; Xiao et al., 2001). We asked
if IKK1 is also required for activation of RelA dimers in
response to LTbR signaling. Consistent with previous
analyses (Derudder et al., 2003), ikk1/ MEF did not
show processing of p100 upon LTbR activation, and this
could be restored upon retroviral reconstitution (Fig-
ure S4A). Whereas TNF activation of NF-kB was un-
affected (Figure 4A, bottom panel), we did not detect
inducible NF-kB activity containing either RelA or RelB in
IKK1-deficient cells in response to LTbR signaling (top
panel). Similarly, MEF derived from NIK knockout mice
or from the alymphoplasia mutant mouse strain (NIK-
aly), which contains an inactivating mutation in NIK (Shin-
kura et al., 1999), showed not only a complete abrogation
of RelB but also RelA dimer activation upon LTbR stimula-
tion (Figures 4B and S4B). Furthermore, shRNA mediated
Figure 4. Signal Transducers of the Noncanonical Pathway Are Required for LTbR-Induced RelA Dimer Activation
(A) LTbR- and TNF-induced NF-kB DNA binding activities were monitored by EMSA in ikk1/MEF reconstituted with an IKK1-expressing retrovirus
(lanes 5–8) and parental IKK1-deficient MEF (lanes 1–4). Arrows indicate specific NF-kB-DNA complexes.
(B) NF-kB DNA binding activities induced by LTbR stimulation in nik/ (lanes 5–8) and control wild-type (lanes 1–4) MEF was monitored
by EMSA.
(C) NF-kB DNA binding activities induced by LTbR stimulation in ikba/b/3/ MEF (lanes 5–8) or such IkBa/b/3-deficient cells in which NIK
expression was knocked down by lentiviral shRNA expression were monitored by EMSA.
(D) The requirement for NEMO in LTbR activation of NF-kB was examined by EMSA of LTbR stimulated nemo/ MEF.
(E) Induction of RelA- and RelB-containing dimers was assessed by immuno-ablation of the complexes with the indicated supershift antibody.
(F) A schematic model of two pathways leading to the activation of NF-kB/RelA:p50 activity. The canonical IkB proteins IkBa, -b, and -3 mediate
RelA:p50 activation in response TNFR stimulation downstream of NEMO and IKK2. We propose that the noncanonical IkB protein p100/IkBd
inhibits the DNA binding activity of both RelA:p50 and RelB:p50 dimers and mediates their activation in response to LTbR stimulation down-
stream of NIK and IKK1.knockdown of NIK by lentiviral vectors in ikba/b/3/
cells (Figure S4C) dramatically reduced RelA activation in
response to LTbR engagement (Figure 4C). These results
support the notion that noncanonical signaling via NIK
and IKK1 regulates the degradation of nfkb2 p100 to affect
NF-kB/RelA activation.
A hallmark of canonical NF-kB signaling is the require-
ment for NEMO in inflammatory stimulus-responsive
degradation of canonical IkB proteins. However, p100
processing to p52 upon LTbR activation was found to be
intact in nemo/ MEF (Dejardin et al., 2002; Muller and
Siebenlist, 2003). Our EMSA analysis confirmed that
nemo/ MEF fail to induce NF-kB activity upon TNF
treatment (Figure S4D), but we found strong induction of
NF-kBDNA binding activity in response to LTbR treatment
(Figure 4D). DNA binding analysis performed in the pres-
ence of RelB or RelA supershift antibody revealed that
both RelA:p50 and RelB:p50 activities remained inducible
in the absence of NEMO (Figures 4E and S4E).Our results suggest a newmodel for theactivationmech-
anismofNF-kB/RelAdimers in response toLTbRsignaling.
While LTbR signaling was proposed to bifurcate into the
NEMO-IKK2-IkB-RelA and the IKK1-p100-RelB axes, our
new understanding of the pathway suggests that p100 is
associated with pre-existing RelA:p50 and RelB:p50 di-
mers (Figure 4F). NIK and IKK1 regulate the signal-respon-
sive proteolysis of p100/IkBd, which results in nuclear
RelA:p50 and RelB:p50 DNA binding activity in a NEMO-
independentmanner. Continued synthesis andprocessing
of p100 to p52 may enhance the level of p52 containing
NF-kB DNA binding complexes at later time points
(Dejardin et al., 2002; Muller and Siebenlist, 2003).
By investigating the mechanisms responsible for RelA
dimer activation upon LTbR stimulation, we identified
p100 as a stimulus-selective signal transducer that
satisfies two criteria of bona fide IkB proteins: the ability
to (1) sequester latent NF-kB dimers and (2) release the
bound dimers via stimulus-induced proteolysis. WhileCell 128, 369–381, January 26, 2007 ª2007 Elsevier Inc. 375
Figure 5. A Single NF-kB Signaling Module Mediates NF-kB RelA Activation in Response to Inflammatory and Developmental
Signals
(A) A schematic presentation of the NF-kB signaling module that includes three canonical IkB proteins IkBa, -b, and -3 that mediate signals from
IKK2-inducing stimuli and the noncanonical IkB protein p100/d that mediates signals from IKK1 inducing stimuli. IkBa, IkB3, and p100 are encoded
by NF-kB response genes and are able to provide negative feedback. Biochemical reactions encompassed in the yellow box are represented as
ordinary differential equations in a mathematical model (version 3.0, see Supplemental Data).
(B) Computational simulations of the dynamic regulation of nuclear RelA:p50 activity (top panels, red), total cellular protein levels of canonical IkB
proteins (middle panels, green) and noncanonical IkB protein p100 (bottom panels, blue). Simulations are shown for the IKK2-inducing inflammatory
stimuli TNF (left column) and LPS (center column) and the IKK1-inducing developmental signals mediated by LTbR (right column).p100/IkBd is a bona fide IkB protein, it differs from the
canonical IkB proteins IkBa, -b, and -3 in its ability to
sequester not only RelA- but also RelB-containing dimers
and in its responsiveness to noncanonical (e.g., LTbR,
BAFFR) rather than canonical (e.g., TNFR and TLR) signal-
ing pathways. Thus, we propose to distinguish between
the canonical IkB proteins IkBa, -b, and -3 and the nonca-
nonical IkB protein p100/IkBd.
Mathematical Reconstruction of Noncanonical
Signaling to NF-kB/RelA
Our new understanding expands the NF-kB signaling
module to include nfkb2 p100/IkBd as a fourth IkB that
controls NF-kB/RelA activity in response to noncanonical,
IKK1-inducing stimuli (Figure 5A). Studies of the dynamic
behavior of the canonical IkB proteins have resulted in
important insights about NF-kB signaling and stimulus-
specific gene expression (Hoffmann et al., 2002; Kearns
et al., 2006; Werner et al., 2005) in response to inflamma-
tory stimuli. To investigate how the dynamics of p100
regulation affect RelA activation in response to noncanon-
ical signaling, we described the synthesis, degradation,
and molecular interactions of p100 with ordinary differen-
tial equations (see Supplemental Data) and included them376 Cell 128, 369–381, January 26, 2007 ª2007 Elsevier Inc.in a mathematical model that already recapitulated TNF
and LPS signaling. The resulting model (version 3.0)
includes 98 biochemical reactions, which were parame-
terized based on published measurements, our own mea-
surements, and fitting procedures. For p100 in particular,
we measured mRNA and protein levels and their half-lives
in resting cells and in response to NF-kB inducing stimuli
(V. Shih, J.K., S.B., A.H., data not shown). Transcriptional
and translational synthesis and degradation rate con-
stants were fitted to these measurements.
The resulting in silicomodel of theNF-kBsignalingmod-
ule predicts NF-kB/RelA:p50 activity in response to either
canonical or noncanonical stimuli, as well as the abun-
dance of the 31 model components including the IkB pro-
teins, free or complexed to IKK or NF-kB, in either the cy-
toplasmor the nucleus (Figure S5andSupplemental Data).
Simulations of LPS and TNF pulse stimulations show the
dynamics of NF-kB activities and cellular canonical IkB
levels (Figure 5B, left and center columns) that match
previous measurements (Werner et al., 2005). Unlike the
canonical IkB proteins, NF-kB p100 is not degraded in
response to IKK2-mediated inflammatory signals (Fig-
ure 5B, bottom row). In contrast, IKK1-mediated LTbR sig-
naling results in p100 degradation while the canonical IkB
Figure 6. nfkb2 p100 Mediates Crosstalk between Inflammatory and Developmental Signals
(A) Cellular levels of canonical (IkBa, -b, and -3; green) and noncanonical (nfkb2 p100, blue) IkB proteins over a 20 hr time course as predicted by
computational simulations of cells stimulated with a 1 hr pulse of TNF. The pie charts indicate the proportion of NF-kB/RelA bound to canonical
IkBs (green) versus the noncanonical IkB (blue) in resting (left) versus TNF-primed (right) cells.
(B) Immunoblots for canonical IkBa and -b and noncanonical p100/d protein of whole-cell lysates prepared at the indicated times fromwild-typeMEF
that were transiently stimulated with 1 ng/ml of TNF for 1 hr.
(C) EMSA for NF-kB activity liberated by deoxycholate (DOC) treatment of cytoplasmic extracts prepared from naı¨ve (top panel) or TNF-primed
(bottom panel) MEF. Prior to DOC treatment extracts were either mock, IkBa, or p100/d-immunodepleted. RelA:p50 DNA binding complexes are
indicated by the arrow.
(D) Computational simulations of RelA:p50 activity induced by LTbR stimulation of naı¨ve or TNF-primed cells.
(E) Experimental analysis of LTbR signaling in naı¨ve or TNF-primed cells. Cells were harvested at indicated time points after LTbR stimulation, and
nuclear extracts were tested for RelA:p50 DNA binding activity by EMSA.
(F) Immunoblotting of nuclear RelA protein (top) during LTbR time course in naı¨ve and TNF-primed cells. An immunoblot for TAF20 (bottom) served
as a loading control.
(G) RNase protection assay to monitor the expression of NF-kB response genes induced by LTbR stimulation in naı¨ve (left) and TNF-primed
cells (right).proteins are unaffected (Figure 5B, right column). Most im-
portantly, the model recapitulates our measurements of
slow induction of nuclear NF-kB/RelA activity that reaches
a maximum at 5–15 hr (Figure S1B).
Crosstalk between Canonical and Noncanonical
Signaling
Given that nfkb2 p100, like IkBa and IkB3 (Kearns et al.,
2006), is an NF-kB target gene, we used computational
simulations to explore feedback regulation and the
dynamics of p100 protein levels in a variety of stimulation
regimes. Remarkably, we found that a 1 hr pulse of TNFstimulation resulted in an elevation of p100protein of about
4-fold that persisted for more than 20 hr (Figure 6A, top
graph). In contrast, graphing the sum of all canonical IkB
proteins revealed the expected transient trough and rapid
recovery. In sum, the model predicted that the fraction of
p100-associated RelA protein at the 20 hr time point to
be increased 3- to 4-fold (Figure 6A, bottom graph).
We examined these predictions experimentally. Immu-
noblotting of total cellular IkB protein confirmed that
p100 protein is induced by 1 hr TNF pulse stimulation,
while the levels of canonical IkBproteins were not discern-
ibly different (Figure 6B). By quantitating IkB-NF-kBCell 128, 369–381, January 26, 2007 ª2007 Elsevier Inc. 377
interactions with the DOC-EMSA assay coupled to immu-
nodepletions, we found that TNF-primed cells contained
much more p100-NF-kB complexes than unstimulated/
naı¨ve cells (Figure 6C). These data confirm the model’s
prediction that priming of cells can shift the balance of la-
tent NF-kB associated with canonical or noncanonical IkB
proteins.
This shift in the IkB homeostasis may have functional
consequences. Computational simulations of LTbR sig-
naling in naı¨ve and TNF-primed cells led to the prediction
that primed cells may respond with a stronger NF-kB
activation profile (Figure 6D). This prediction is remarkable
because in the simulated stimulation regimen canonical
signaling has long ceased when cells are exposed to
agonist antibody, and it thus not only constitutes an exam-
ple of signaling crosstalk but also of cellular memory. We
examined the prediction experimentally. Our EMSA and
nuclear Immunoblot results confirmed that 2- to 3-fold
more NF-kB/RelA activity is induced by LTbR stimulation
in cells that were previously primed with TNF (Figures 6E
and 6F).
We investigated the gene-expression effects of this
elevated NF-kB response using quantitative multiplex
RNase protection assays. While naı¨ve MEF did not show
appreciable inflammatory gene activation in response to
the LTbR stimulation, primed MEF exhibited induction
not only of the IkBa gene, a hallmark of the canonical
NF-kB response, but also the gene encoding the inflam-
matory cytokine TNF (Figure 6G). These results constitute
qualitative changes in stimulus-responsive gene expres-
sion programs. Our computational simulations of the NF-
kB signalingmodule revealed that the homeostatic control
of IkB signal transducers integrates the history of cellular
exposure to NF-kB inducing stimuli. Our experimental
results confirmed the validity of the proposed model and
resultant crossregulatory mechanism between canonical
and noncanonical NF-kB inducing signals and revealed
that its functional consequences for stimulus-specific
gene expression programs may be profound.
Genetic Perturbations of IkB Homeostasis
The homeostasis of canonical and noncanonical IkB
proteins may not only be subject to physiological stimuli,
but altered homeostasis due to genetic aberrations may
be the underlying cause for pathological misregulation of
stimulus-specific gene expression. To examine this possi-
bility and further test the validity of our mathematical
model, we used computational simulations to predict the
relative amounts of p100 protein in a panel of cells defi-
cient for one or more canonical IkB proteins. For example,
cells deficient in IkBa were predicted to have 2-fold more
p100 protein than wild-type cells (Figure 7A). Similarly,
doubly-deficient and triply-deficient cells are predicted
to show further increases in p100 except for IkBb/3-defi-
cient cells, in which p100 levels were predicted to be
near wild-type. Immunoblotting for p100 with extracts
derived from these different cell lines confirmed this pre-
diction (Figure 7B); in particular, we observed no signifi-378 Cell 128, 369–381, January 26, 2007 ª2007 Elsevier Inc.cant increases in p100 levels in IkBb/3-deficient cells
while immunoblot signals were elevated in other knock-
outs as predicted.
Altered balances in the canonical and noncanonical IkB
proteinsmay be expected to lead to alterations in the LTbR
responsiveness. Computational simulations indeed pre-
dicted that NF-kB/RelA responses to agonist receptor
would be highest in IkB triple-knockout and IkBa/3-defi-
cient cells, intermediate in IkBa- and IkBa/b-deficient
cells, and relatively low in wild-type and IkBb/3-deficient
cells (Figure 7C). The results from experimental analysis
using EMSA of nuclear extracts prepared from LTbR-
stimulated cells of each respective genotype were in over-
all agreement with these simulations (Figure 7D). These
results suggested that genetic alterations in cells that
constitutively alter the homeostasis of canonical and
noncanonical IkB proteins affect the stimulus-specific
activation of NF-kB. To determine whether these changes
are functionally relevant, we examined the expression of
knownNF-kB response genes. Indeed, we found that cells
that showed hyperresponsive NF-kB/RelA activation to
LTbR stimulation also exhibited inflammatory gene ex-
pression, such as those encoding iNOS, MIP-2, IP-10,
KC, or GM-CSF, not normally seen in wild-type MEF
(Figure 7E). These effects were not merely quantitative
but qualitative. Of the six target genes we examined we
found a range of responsiveness that suggests that NF-
kB target genesmayhavedifferent threshold requirements
for NF-kB activity that allow for differential regulation.
Canonical and Noncanonical IkBs in Physiology
and Pathology
Our results offer a significant revision of our understanding
of NF-kB signaling. By examining the mechanism for
NF-kB/RelA activation in response to LTbR signaling, we
identified nfkb2 p100 as the pertinent signal transducer
that functions as a bona fide IkB molecule. We propose
that as a feedback regulator of the RelA:p50 transcrip-
tional activator the noncanonical IkB protein p100 repre-
sents an integrator of canonical and noncanonical signals.
The resulting signaling crosstalk between inflammatory
and developmental stimuli suggests that the canonical
and noncanonical NF-kB signaling pathways (previously
described as separate) ought to be considered as being
contained within a single signaling module. The ‘‘four
IkB’’ computational model that integrates IKK1- and IKK2-
mediated signals represents a first attempt in that direc-
tion. Future efforts will have to quantitatively address the
regulation of RelB complexes and the generation of p52-
containing dimers.
Within their physiological environment, cells receive
multiple signals, and thus the potential for signaling cross-
talk is significant. Relevant to lymphnode development,
constitutive TNF signaling has been observed in the
spleen (Schneider et al., 2004). Indeed, the in vitro gener-
ation of fibroblast reticular cells from lymphnode tissue
requires both TNFR and LTbR stimulation (Katakai et al.,
2004), while abrogation of TNF signaling in vivo results in
Figure 7. Misregulation of Canonical and Noncanonical IkB Homeostasis Alters Stimulus-Specific Gene Expression
(A) Cellular protein levels of canonical (IkBa, -b, and -3; green) and noncanonical (nfkb2 p100, blue) IkB proteins in unstimulated cells of the indicated
genotype as predicted by computational simulations.
(B) Quantitative immunoblots for p100 of lysates prepared from equivalent number of wild-type or mutant MEF deficient of the indicated genotype.
(C) Computational simulations of nuclear RelA:p50 activity induced by LTbR stimulation in cells of the indicated genotype.
(D) EMSA for NF-kB binding activity of nuclear extracts prepared from LTbR-stimulated cells of the indicated genotype. Wild-type or mutant MEF that
lack one or more IkB isoforms were stimulated with LTbR for the indicated times.
(E) RNase protection assay to monitor the expression of the indicated NF-kB response genes induced by LTbR stimulation in cells of the indicated
genotype.the loss of lymphnode architecture (Rennert et al., 1998).
Fundamentally, all cells are continuously subject to low
or varying amounts of TLR/TNFR signaling, albeit these
conditions are not usually reproduced in sterile in vitro
cell-culture conditions. Recent in vivo studies suggest
that naı¨ve T cell responses are regulated by integrating sig-
nals frommemory and regulatory T cells via p100 (Ishimaru
et al., 2006). Remarkably, nfkb2 p100-mediated crosstalk
does not have to occur coincidently but integrates the
history of cellular exposure to inflammatory signals.
Conversely, our studies demonstrate that alterations in
the homeostasis of IkB proteins can result in inappropriate
expression of inflammatory genes in response to develop-
mental/noncanonical LTbR signaling. We utilized defined
genetic mutants with altered IkB protein expression
patterns. These cells may serve as model systems for
disease-associated misregulation. In this context, it is of
interest to note that a significant fraction of malignantReed Sternberg cells in Hodgkin’s lymphoma has defec-
tive IkBa genes (Krappmann et al., 1999). Our findings
suggest that pathogenic misregulation of gene expression
in Reed Sternberg cells may in part be the result of nonca-
nonical developmental signals impinging on an NF-kB
signaling module with an altered homeostasis of IkB
proteins. We suggest that the integration of multiple sig-
nals via signaling crosstalk represents an opportunity for
therapeutic intervention, which may be more effectively
exploited through the combined tools of computational
modeling and biochemical analysis.
EXPERIMENTAL PROCEDURES
Cell Culture and Reagents
Primary and 3T3 immortalized MEF were generated from E12.5–14.5
embryos and maintained as previously described (Hoffmann et al.,
2003). Generation of ikba/b/3/ and ikba/b/3/rela/ cellCell 128, 369–381, January 26, 2007 ª2007 Elsevier Inc. 379
lines will be described elsewhere. Agonistic LTbR monoclonal anti-
body raised in hamster (AF.H6) was obtained from Jeff Browning (Bio-
gen, Inc). Two other previously used Rat anti-LTbR antibodies, 3C8
and 4H8 (Dejardin et al., 2002), were also used (Figure S1F). Recombi-
nant murine TNF was from Roche. RelA/p65 (sc-372), RelB (sc-226),
cRel (sc-71), IkBa (sc-371), IkBb (sc-946), and NIK (H-248) antibodies
were from Santa Cruz Biotechnology. Phospho-IkBa (Ser-32 and Ser-
36) monoclonal antibodywas fromCell Signaling Technology. N-termi-
nal p52 (1495), p50 (1157 and 1263) as well as C-terminal anti-sera for
p100 (1310) and p105 (1140) were a generous gift from Nancy Rice.
Antiserum against TAF20 was used to test nuclear fractionation. Sc-
372G antibody was used for RelA immunoprecipitation and sc-226
crosslinked to protein-A-sepharose beads was used for RelB immuno-
precipitate. Supershift antibodies have been described previously
(Hoffmann et al., 2003).
Immunoblot, Immunoprecipitation, and Kinase Assay
Whole-cell extracts were prepared in RIPA buffer and normalized be-
fore immunoblot analysis. For immunoprecipitation-western analysis,
whole-cell lysate from 106 cells was prepared in buffer containing
20% glycerol, 0.2 mM EDTA, 0.5% NP-40, and 150 mM NaCl. Band
intensities were quantitated by phosphor-imager and normalized
against the respective actin band. To evaluate the DOC sensitivity of
RelA-p100 interactions, RelA immunoprecipitates obtained from cyto-
solic extract were washed with buffer containing 10 mM HEPES-KOH,
pH 7.9, 150 mM KCl, 1 mM EDTA, and 0.1% NP-40 containing 0%,
0.3%, or 0.8% deoxycholate. Washes and SDS sample buffer-eluted
immunopellets were immunoblotted. IKK kinase assays were per-
formed as described (Werner et al., 2005).
Pulse-Chase Metabolic Labeling
In vivo pulse labeling of MEF was done with 100 mCi/ml trans 35S-Met
label (MP Biomedicals, Inc.) using the indicated time courses. p52/
p100 were immunoprecipated (N-terminal antiserum 1495) from
RIPA lysate. Proteins were resolved in 8% SDS-PAGE and visualized
by autoradiography.
Retrovirus Mediated Gene Transduction
IKK1 and p100, p1001-774 or p52 expressing retroviral constructs were
gifts from M. Karin and A. Rabson. pBabe.IkBd.puro was constructed
by PCR amplifying C-terminal region of p100 encoding amino acids
(483–934) using pBabe.p100.puro as template. Retroviral constructs
were cotransfected with pCL.Eco into 293T cells, and 42 hr posttrans-
fection filtered supernatant was used to infect MEF. Transduced cells
were selected with puromycin hydrochloride (Sigma).
Lentiviral Delivery of shRNA
Lentiviral constructs expressing shRNAs against nfkb2 and nik genes
and control oligos were packaged into viruses as described previously
(Tergaonkar et al., 2005). Sequences for specific oligo used in knock-
down studies are available upon request. Four different control shRNA
were used (Figure S2E) to ensure functional specificity.
TAP-p65 Complex Purification and Mass Spectrometry
Murine rela gene was cloned into pRAV-Flag-TAP bicistronic retroviral
vector that expresses EGFP from an internal ribosome entry site (IRES)
promoter (Knuesel et al., 2003). Tagged-rela gene was transduced into
ikba/b/3/rela/ cell line, and stable expressors were obtained
by GFP-mediated fluorescence cell sorting. IgG binding domain-
tagged p65 and interacting proteins were immunoprecipitated from
the cell extract (from 108 cells) using IgG-Sepharose 6 Fast Flow
resin (Amersham Biosciences). Flag-RelA was eluted from the immu-
nopellet by TEV-protease cleavage (Invitrogen) and reprecipitated
with anti-Flag M2 affinity gel resin (Sigma). RelA complexes were
eluted with 1 mg/ml Flag peptide (Sigma) and were analyzed by
SDS-PAGE. Gel slices were cut, and in-gel trypsin digested and ana-380 Cell 128, 369–381, January 26, 2007 ª2007 Elsevier Inc.lyzed by LC-MS/MS at the Scripps Research Institute Center for
Mass Spectrometry and searched against MASCOT/BLAST.
DNA Binding Assays
EMSAs were done as described with a kB site containing probe that
binds to both RelA and RelB dimer with similar affinities (Lo et al.,
2006). Super-shift assays were done with antibodies as described
before (Hoffmann et al., 2003). For DOC sensitivity, 2 mg of cytosolic
extract was treated with final 0.8% DOC for 30 min and subsequently
subjected to EMSA analysis. Where specified, cytosolic extracts were
immunodepleted for indicated protein prior to DOC treatment.
RNase Protection Assays
Total RNA was extracted from stimulated fibroblast using Trizol re-
agent. RPA was performed with 5 mg RNA using Riboquant probe
set (BD-Bioscience) according to manufacturers’ protocols.
Computational Modeling
The previously described mathematical model (Werner et al., 2005)
was extended to include nfkb2 p100 and noncanonical signaling via
IKK1 as shown in Figure S5 and described in detail in the Supplemental
Data. Simulations were done in Matlab version 2006a (Mathworks)
using the built-in ode15s solver at default settings.
Supplemental Data
Supplemental Data include five figures, four tables, Supplemental
Experimental Procedures, and Supplemental References and can be
found with this article online at http://www.cell.com/cgi/content/full/
128/2/369/DC1/.
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